Skip to content

Clinical trials

Adenocarcinoma trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Country / region: Switzerland Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20082
20111
20141
20151
20163
20181
20202
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting3
Terminated2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Zurich3
Novartis Pharmaceuticals2
Ariad Pharmaceuticals1
Boston Scientific Corporation1
Centre Hospitalier Universitaire Vaudois1
EMD Serono Research & Development Institute, Inc.1
Hoffmann-La Roche1
Merck KGaA, Darmstadt, Germany1
Swiss Cancer Institute1
University Hospital, Basel, Switzerland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma14
Carcinoma4
Lung Neoplasms4
Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Neoplasms by Histologic Type2
Neoplasms by Site2
Pancreatic Neoplasms2
Stomach Neoplasms2
Breast Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.